simvastatin has been researched along with Nephrotic Syndrome in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 13 (65.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; Jiang, L; Kong, X; Li, Z; Wu, T; Yuan, H | 1 |
| Chan, AO; Chan, GP; Chan, YH; Chau, KF; Cheung, CY; Lau, GT; Lee, KC; Li, CS; Shek, CC | 1 |
| Akbaş, H; Akkaya, B; Akman, S; Baysal, YE; Guven, AG; Kalay, S; Koyun, M | 1 |
| Danielson, C; Houseworth, J; Jackson, L; McCarthy, L; Skipworth, E | 1 |
| Cui, HM; Ma, CY; Wei, JL | 1 |
| Basal, S; Caglar, K; Eyileten, T; Ipcioglu, OM; Kaya, A; Korkmaz, A; Oguz, Y; Sonmez, A; Topal, T; Vural, A; Yenicesu, M; Yilmaz, MI | 1 |
| Böhler, J; Eckardt, HG; Schollmeyer, P; Wanner, C; Wieland, H | 1 |
| Harris, KP; Hattersley, JM; Moorhead, JF; Ramaswamy, C; Thomas, ME; Varghese, Z; Walls, J; Wheeler, DC; Williams, JD | 1 |
| Hendry, BM; Owen, JS; Scoble, JE; Streather, CP | 1 |
| Coleman, JE; Watson, AR | 1 |
| Byrne, MJ; Rayner, BL; van Zyl Smit, R | 1 |
| Kashihara, N; Makino, H; Maruyama, K; Miyatake, N; Ogawa, D | 1 |
| Harmos, G; Révai, T | 1 |
| Chan, NN | 1 |
| Brunton, C; Moorhead, JF; Varghese, Z | 1 |
| Basten, A; Olbricht, CJ; Thiery, J; Wanner, C | 1 |
| Boulton-Jones, JM; Grierson, D; Murray, L; Packard, CJ; Shepherd, J; Stewart, JP; Warwick, GL | 1 |
| Erkelens, DW; Hené, RJ; Joles, JA; Koomans, HA; Rabelink, AJ | 2 |
| Moorhead, JF; Thomas, M | 1 |
1 review(s) available for simvastatin and Nephrotic Syndrome
| Article | Year |
|---|---|
Lipid-lowering agents for nephrotic syndrome.
Topics: Adult; Child; Fatty Acids, Monounsaturated; Fluvastatin; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Indoles; Lovastatin; Nephrotic Syndrome; Randomized Controlled Trials as Topic; Simvastatin | 2013 |
7 trial(s) available for simvastatin and Nephrotic Syndrome
| Article | Year |
|---|---|
Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome.
Topics: Adult; Female; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes, Mononuclear; Male; Nephrotic Syndrome; Plasminogen Activator Inhibitor 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Thromboplastin | 2007 |
Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome.
Topics: Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoprotein(a); Lipoproteins; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Simvastatin | 1994 |
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Double-Blind Method; Female; Humans; Hypercholesterolemia; Inulin; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Placebos; Proteinuria; Simvastatin; Triglycerides | 1993 |
A prospective clinical trial comparing the treatment of idiopathic membranous nephropathy and nephrotic syndrome with simvastatin and diet, versus diet alone.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, Dietary; Combined Modality Therapy; Enzyme Inhibitors; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Nephrotic Syndrome; Prospective Studies; Serum Albumin; Simvastatin; Time Factors | 1996 |
Lipopheresis in the nephrotic syndrome.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Female; Humans; Lipoprotein(a); Male; Middle Aged; Nephrotic Syndrome; Simvastatin; Time Factors; Treatment Outcome | 1999 |
Partial remission of nephrotic syndrome in patient on long-term simvastatin.
Topics: Aged; Anticholesteremic Agents; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Remission Induction; Simvastatin | 1990 |
Effects of simvastatin and cholestyramine on lipoprotein profile in hyperlipidaemia of nephrotic syndrome.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Random Allocation; Simvastatin | 1988 |
12 other study(ies) available for simvastatin and Nephrotic Syndrome
| Article | Year |
|---|---|
A rare cause of nephrotic syndrome: lipoprotein glomerulopathy.
Topics: Adult; Apolipoproteins E; DNA Mutational Analysis; Glomerulonephritis; Hong Kong; Humans; Hypolipidemic Agents; Lipoproteins; Male; Mutation; Nephrosis, Lipoid; Nephrotic Syndrome; Polymerase Chain Reaction; Proteinuria; Simvastatin | 2009 |
Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Enalapril; Immunoglobulins; Immunologic Factors; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar; Simvastatin; Time Factors; Treatment Outcome | 2009 |
Transfusion medicine illustrated: an unusual plasmapheresis product.
Topics: Adult; Glomerulosclerosis, Focal Segmental; Humans; Hyperlipidemias; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Plasma Exchange; Simvastatin | 2003 |
Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Cilazapril; Combined Modality Therapy; Disease Models, Animal; Doxorubicin; Glutathione Peroxidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperbaric Oxygenation; Kidney; Male; Nephrotic Syndrome; Oxidative Stress; Protein Carbonylation; Proteinuria; Rats; Rats, Sprague-Dawley; Simvastatin; Superoxide Dismutase | 2008 |
Incubation of porcine high-density lipoprotein with the apical surface of LLC-PK1 renal tubular cells sustains the properties of orientated monolayers.
Topics: Albumins; Animals; Cell Membrane; Cell Membrane Permeability; Cells, Cultured; Hypolipidemic Agents; Inulin; Kidney Tubules, Proximal; Lipoproteins, HDL; LLC-PK1 Cells; Lovastatin; Mevalonic Acid; Monosaccharide Transport Proteins; Nephrotic Syndrome; Simvastatin; Swine | 1996 |
Hyperlipidaemia, diet and simvastatin therapy in steroid-resistant nephrotic syndrome of childhood.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Combined Modality Therapy; Creatinine; Diet; Drug Resistance; Enzyme Inhibitors; Feeding Behavior; Female; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Infant; Lovastatin; Male; Nephrotic Syndrome; Retrospective Studies; Serum Albumin; Simvastatin; Triglycerides | 1996 |
Concomitant use of simvastatin and cyclosporin A increases LDH in nephrotic syndrome.
Topics: Adolescent; Cyclosporine; Drug Combinations; Female; Humans; L-Lactate Dehydrogenase; Nephrotic Syndrome; Simvastatin | 1998 |
Simvastatin treatment in nephrotic syndrome associated with a bee sting.
Topics: Adolescent; Animals; Bees; Female; Humans; Hypolipidemic Agents; Insect Bites and Stings; Nephrotic Syndrome; Simvastatin | 1999 |
Statin therapy in nephrotic syndrome.
Topics: Coronary Disease; Humans; Hypolipidemic Agents; Nephrotic Syndrome; Simvastatin | 1999 |
Simvastatin in nephrotic syndrome. Simvastatin in Nephrotic Syndrome Study Group.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Multicenter Studies as Topic; Nephrotic Syndrome; Prospective Studies; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome; Triglycerides | 1999 |
Effect of simvastatin on plasma lipid and lipoprotein concentrations and low-density lipoprotein metabolism in the nephrotic syndrome.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Nephrotic Syndrome; Simvastatin | 1992 |
Nephrotic syndrome and simvastatin.
Topics: Albuminuria; Anticholesteremic Agents; Follow-Up Studies; Humans; Lovastatin; Nephrotic Syndrome; Simvastatin | 1990 |